Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement--Groupe des Chirurgiens de la Federation des Centres de Lutte Contre le Cancer.

PURPOSE To determine the rate of nonsentinel lymph node (NSN) involvement at axillary lymph node dissection (ALND) and predictive factors of this involvement following detection of micrometastasis in sentinel nodes (SN). METHODS We analyzed 700 observations of SN micrometastases with additional ALND with the characteristics of the patients, tumors, and SN. RESULTS Involvement of SN was diagnosed 388 times by serial sections (55.4%) with standard hemoxylin and eosin staining (HES) and 312 times solely on immunohistochemical analysis (IHC; 44.6%). The accurate size of the micrometastases was indicated in 488 cases: 301 larger than 0.2 mm (61.7%) and 187 < or = 0.2 mm (38.3%). Ninety-four patients (13.4%) presented an NSN involvement with only one NSN involved in 62 cases (66%). Predictive factors of NSN involvement were in univariate analysis (pT stage [P < .000], menopausal status [P = .048], T stage [P = .006], grade [P = .013], lymphovascular invasion [LVI; P = .013], histologic tumor type [P = .017], and method of micrometastasis detection, by HES or IHC [P = .015]) and in multivariate analysis (pT stage < or = or > 20 mm [odds ratio, 2.54], micrometastases detected by HES or IHC [odds ratio,1.734], presence or absence of LVI [odds ratio, 1.706]). Micrometastasis size < or = or greater than 0.2 mm was not predictive. CONCLUSION This study confirms the value of serial sections and the vital role played by IHC in screening for small micrometastases. Omission of additional ALND may be envisaged with minimal risk for pT1a and pT1b tumors, and pT1a-b-c tumors corresponding to tubular, colloidal, or medullar cancers.

[1]  L. Strobbe,et al.  Can the Memorial Sloan-Kettering Cancer Center Nomogram Predict the Likelihood of Nonsentinel Lymph Node Metastases in Breast Cancer Patients in The Netherlands? , 2005, Annals of Surgical Oncology.

[2]  A. Luini,et al.  Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  G. Pruneri,et al.  Predicting the Risk for Additional Axillary Metastases in Patients With Breast Carcinoma and Positive Sentinel Lymph Node Biopsy , 2005, Annals of surgery.

[4]  C. Fournier,et al.  Surgical implications of sentinel node with micrometastatic disease in invasive breast cancer. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[5]  A. Sapino,et al.  Meta‐analysis of non‐sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer , 2004, The British journal of surgery.

[6]  H. Cody,et al.  The Risk of Axillary Relapse After Sentinel Lymph Node Biopsy for Breast Cancer Is Comparable With That of Axillary Lymph Node Dissection: A Follow-up Study of 4008 Procedures , 2004, Annals of surgery.

[7]  C. Julian‐Reynier,et al.  Patients' and surgeons' perspectives on axillary surgery for breast cancer. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  S. Bose,et al.  Prediction of Additional Axillary Metastasis of Breast Cancer Following Sentinel Lymph Node Surgery , 2004, The breast journal.

[9]  D. Nitti,et al.  Number of Metastatic Sentinel Nodes As Predictor of Axillary Involvement in Patients with Breast Cancer , 2004, Breast Cancer Research and Treatment.

[10]  D. McCready,et al.  Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and false-negative rates. , 2004, Journal of the National Cancer Institute.

[11]  A. Troxel,et al.  Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis. , 2004, Archives of surgery.

[12]  D. Landsittel,et al.  Sentinel Lymph Node Micrometastasis as a Predictor of Axillary Tumor Burden , 2004, The breast journal.

[13]  P. Dudrick,et al.  Nonsentinel Lymph Node Status after Positive Sentinel Lymph Node Biopsy in Early Breast Cancer , 2004, The American surgeon.

[14]  E. McDermott,et al.  Factors affecting metastases to non-sentinel lymph nodes in breast cancer , 2003, Journal of clinical pathology.

[15]  X. Sastre-Garau,et al.  Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases , 2003, The British journal of surgery.

[16]  Hiram S. Cody,et al.  A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy , 2003, Annals of Surgical Oncology.

[17]  Umberto Veronesi,et al.  A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. , 2003, The New England journal of medicine.

[18]  V. Bardou,et al.  Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer? , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  J. Peterse,et al.  Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. , 2003, European journal of cancer.

[20]  J. Donohue,et al.  Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. , 2003, Archives of surgery.

[21]  G. Houvenaeghel,et al.  Du risque de sous-traitement des cancers du sein en utilisant la technique du ganglion sentinelle , 2003 .

[22]  F. Peintinger,et al.  Sentinel lymph node biopsy alone without axillary lymph node dissection--follow up of sentinel lymph node negative breast cancer patients. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[23]  Kelly K. Hunt,et al.  Clinicopathologic Factors Predicting Involvement of Nonsentinel Axillary Nodes in Women With Breast Cancer , 2003, Annals of Surgical Oncology.

[24]  M. Noguchi,et al.  Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes , 2002, The British journal of surgery.

[25]  B. Cady,et al.  Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. , 2002, American journal of surgery.

[26]  D. Reintgen,et al.  Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes. , 2002, American journal of surgery.

[27]  I. Treilleux,et al.  Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[28]  Jong-Hyeon Jeong,et al.  Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. , 2002, The New England journal of medicine.

[29]  A. Vincent-Salomon,et al.  Histological Detection of Minimal Metastatic Involvement in Axillary Sentinel Nodes: A Rational Basis for a Sensitive Methodology Usable in Daily Practice , 2002, Modern Pathology.

[30]  A. Giuliano,et al.  Proceedings of the Consensus Conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania , 2002, Cancer.

[31]  S. Jaffer,et al.  Predictors of nonsentinel lymph node metastasis in breast cancer patients. , 2002, American journal of surgery.

[32]  R. Roumen,et al.  Treatment of 100 patients with sentinel node‐negative breast cancer without further axillary dissection , 2001, The British journal of surgery.

[33]  J. Frisell,et al.  Multicentre study of detection and false‐negative rates in sentinel node biopsy for breast cancer , 2001, The British journal of surgery.

[34]  T. Nims,et al.  Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node? , 2001, American journal of surgery.

[35]  J. Boyages,et al.  Treatment implications of a positive sentinel lymph node biopsy for patients with early‐stage breast carcinoma , 2001, Cancer.

[36]  A. Luini,et al.  Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma , 2001, Cancer.

[37]  G. Mariani,et al.  Technical issues and pathologic implications of sentinel lymph node biopsy in early‐stage breast cancer patients , 2001, Journal of surgical oncology.

[38]  D. Reintgen,et al.  Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. , 2001, Archives of surgery.

[39]  K. McMasters,et al.  Predicting the status of the nonsentinel axillary nodes: a multicenter study. , 2001, Archives of surgery.

[40]  H. Cody,et al.  Lymphovascular Invasion Enhances the Prediction of Non-Sentinel Node Metastases in Breast Cancer Patients With Positive Sentinel Nodes , 2001, Annals of Surgical Oncology.

[41]  G. Viale,et al.  Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. , 2001, European journal of cancer.

[42]  A. Giuliano,et al.  Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node , 2000, Cancer.

[43]  L. Sobin,et al.  Classification of isolated tumor cells and micrometastasis , 2000 .

[44]  P. V. van Diest,et al.  The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer. , 2000, Surgery.

[45]  A E Giuliano,et al.  Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  A. Cantor,et al.  Do Cytokeratin-Positive-Only Sentinel Lymph Nodes Warrant Complete Axillary Lymph Node Dissection in Patients with Invasive Breast Cancer? , 2000, The American surgeon.

[47]  B. Gusterson,et al.  Role of immunohistochemical detection of lymph-node metastases in management of breast cancer , 1999, The Lancet.

[48]  J. Donohue,et al.  Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  E. Conant,et al.  Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma , 1999, Cancer.

[50]  R. Foster,et al.  The sentinel node in breast cancer--a multicenter validation study. , 1998, The New England journal of medicine.

[51]  M. Fan,et al.  Lymph node micrometastases from breast carcinoma , 1997, Cancer.

[52]  K. Mimori,et al.  Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. , 1995, Cancer research.

[53]  Alice Chung,et al.  Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer , 1994, Annals of surgery.

[54]  C. Perez,et al.  Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer. , 1993, International journal of radiation oncology, biology, physics.

[55]  J. Coindre,et al.  Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. , 1992, British Journal of Cancer.

[56]  F. Vicini,et al.  Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  S. Love,et al.  Level I and II axillary dissection in the treatment of early-stage breast cancer. An analysis of 259 consecutive patients. , 1990, Archives of surgery.

[58]  Internationalludwigbreastcanc.  Prognostic importance of occult axillary lymph node micrometastases from breast cancers , 1990 .

[59]  D. Schultz,et al.  Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and radiation for early breast cancer. , 1989, International journal of radiation oncology, biology, physics.

[60]  B Fisher,et al.  Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. , 1985, The New England journal of medicine.

[61]  J. Vaidya,et al.  Diseases of the breast , 2000, British Journal of Cancer.

[62]  B. Asselain,et al.  Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  E. Barrera,et al.  Axillary Recurrence After Sentinel Node Biopsy , 2004, Annals of Surgical Oncology.

[64]  J. Boyages,et al.  Competing Considerations in Regional Nodal Treatment for Early Breast Cancer , 2002, The breast journal.

[65]  A. Giuliano,et al.  Sentinel Node Metastasis in Patients with Breast Carcinoma Accurately Predicts Immunohistochemically Detectable Nonsentinel Node Metastasis , 1999, Annals of Surgical Oncology.